News

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...
Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm as a strategic partner.
NSC51349 selectively inhibits cutaneous HPV replication by targeting viral E2 activity, potentially paving the way for first ...
A new machine learning approach identifies cellular senescence at single-cell resolution across varying cell types and tissue ...
Axplora reports that it has invested €35 million ($40.2 million) to expand its Farmabios site in Gropello Cairoli, Italy. This follows a previous €45 million ($52.7 million) investment which brings ...
Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...
Patients on baseline steroids had lower ORR, and markedly shorter PFS survival and OS compared with those not receiving ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
If a gene is evolutionarily conserved, that shows it must be doing something important. Otherwise, nature would let it go.
While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.
Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...
Meteor Biotech’s SLACS platform isolates cells from tissue for multi-omics, advancing cancer, inflammation, and spatial ...